Endpoints News· Reynald Castaneda·· 2 小时前AI 评分42
Novartis 考虑因 MFN 绕过欧洲政府支付方
Novartis considers bypassing European government payers due to MFN
AI 导读
Novartis CEO Vas Narasimhan 表示，因最惠国（MFN）定价影响，正考虑在欧洲通过私人市场或自费市场推出新药。该表态于周二作出，具体方案尚未明确。
正文 · 原文
Novartis CEO Vas Narasimhan said Tuesday that launching new drugs in the private market or in a self-pay market in Europe is not off the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源：Endpoints News · endpoints.news